Replies to post #230977 on Biotech Values

[Biowatch]

COVID-19 saliva test versus nasopharyngeal swabbing

My impression is that the nasopharyngeal swabbing is more likely to pick up traces of the virus in the early stages.

I'm guessing that if it lands in your mouth, the various enzymes and such are likely to digest and destroy it.

If it lands in your nose, your nose hairs are there to slow its passage to your lungs, but may be less likely to kill it.
----
I ran a fever and felt bad the first week of February and went to a Minute Clinic.

The Minute Clinic gave me both nasal and throat swabs, and told me within five minutes that I had Influenza A, and that I didn't have strep throat. This told me to quarantine, and that no antibiotic was needed.

It would be nice to have a Covid test that was as quick.

[jq1234]

From Rutgers own PR:

Soon after the Rutgers-ADL team received notification from the FDA on Saturday, the White House’s COVID-19 testing task force called Brooks to offer congratulations and support and to ask about any specific hurdles to expanding testing and enabling other laboratories to benefit from the accomplishment.

Shortly after the White House call, the research team was contacted by chief executive officers of some of the world’s largest life sciences companies that are involved in COVID-19 testing.

“I have spoken with these companies’ leadership to not only share knowledge but to create opportunities for continuing to help innovate during this crisis,” Brooks said. “We will work closely with these new partners, the FDA and the White House task force to leverage everything Rutgers has to offer to not only help our community but also make a global impact.”


https://www.rutgers.edu/news/new-rutgers-saliva-test-coronavirus-gets-fda-approval